RNL Bio launches a new line of stem cell based cosmetics, dramatically reversing the signs of aging

Dec. 2, 2008 - PRLog -- RNL Bio Co Ltd, a leading biotech dedicated to commercialization of stem cell therapeutics, has introduced its first stem cell based cosmetics brand 'Dr. JUCRE' at Chosun Hotel Sokong on Dec 1st. RNL integrated its innovative stem cell technology into these cosmetics to promote skin anti-aging, rejuvenation and whitening functions. The event was attended by middle aged celebrities, CEO of Seems Inc and representatives from American biotech companies.

Dr. JUCRE products are drawing much attention due to the addition of adult stem cells as their active ingredients. In the past, there have been cosmetics that claim to be stem cell cosmetics however the active ingredients were always drawn from natural or synthetic proteins.  Dr. JUCRE is the world’s first cosmetics line that contains human adipose derived stem cells the active ingredient.

Dr. JUCRE was named after JUvenescence Creation with Cell REgeneration and has the message,'wonderful recreation for the regeneration the new skin'. RNL has developed the brand to turn back the clock on aging skin and bring it closer to when one’s skin was at its prime.  This is the proven regenerative properties that stem cells posses.  

RNL Bio collaborated with Keimyung University in Taegu to test Dr. JUCRE products for efficacy on skin and researchers reported that the products visibly reduced wrinkles and improved skin’s elasticity.  RNL also conducted internal clinical trials with the enrollment of 66 female volunteers from the ages of 37 to 66 for 8 weeks. The study demonstrated that 61.2% of treated subjects had improved moisture, 46.9% experienced more luminosity and transparency and 24.5% of subjects claimed a decrease in the visibility of wrinkles.

Clinically proved Dr. JUCRE Million Stem Cell Magic Concentrate contains one million stem cells per each ample and was designed as a concentrated essence to provide skin with an abundant nourishment. No preservatives are added and the concentrate needs to be refrigerated to ensure the product’s freshness.   The product is sold only by pre-order or appointment.

Mr. Urushihata from Seems Inc, a Japanese biotech that licensed in RNL’s stem cell technology last June, said 'Dr. JUCRE is a remarkable product. We plan to promote the brand through home shopping channels in Japan. The only concern is the limited supply due to the wait time for natural ingredients.

Dr. Jeong Chan Ra, CEO of RNL said 'RPC Therapy (Regenerative Pure Cell Therapy: Dermatological treatment developled by RNL Bio for transparent and younger looking skin through stem cell assisted skin regeneration) is already available at our affiliated hospitals. Dr. JUCRE will help to prolong the effects and reduce the need for frequent treatments. Dr. JUCRE’s cosmetics is the beginning of a new era for cosmetics. RNL Bio has plans to introduce Dr. JUCRE to larger markets in Japan, China and the US and is anticipated to be a global leader in the research and development of innovative and efficacious natural cosmetics.

# # #

RNL Bio has developed technologies for stem cells therapeutics and natural product screening with the mission to extend and ensure the quality of live for all mankind. RNL has operated state of the art family stem cell bank, named Biostar. RNL focuses on the commercialization of stem cell therapeutics for the treatment of diabetes, spinal cord injury, incontinence of urine, Beurger’s disease and osteoarthritis. RNL is a publicly traded company on the Korean Stock Exchange (Code 003190)